Skip to main content
. Author manuscript; available in PMC: 2014 Oct 2.
Published in final edited form as: Clin Cancer Res. 2010 Sep 9;16(21):5351–5361. doi: 10.1158/1078-0432.CCR-10-1265

Figure 3. Expression of the inositol polyphosphate-5-phosphatase (INPP5A) gene in the two response cohorts within the two treatment arms.

Figure 3

INPP5A had the most significant gene expression-treatment arm interaction p-value (p= 0.00193, unadjusted for multiple comparisons). “*” indicates the mean value.

Abbreviations: pCR=pathologic complete response, RD=residual cancer, T/FAC= weekly Paclitaxel and 5-Fluorouracil, Doxorubicin and Cyclophosphamide, FAC= 5-Fluorouracil, Doxorubicin and Cyclophosphamide.